Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Debridement & negative-pressure wound therapy · District of Columbia | Debridement & negative-pressure wound therapy · Florida | |
|---|---|---|
| Surgeons, 2024 | 34 | 1,336 |
| Medicare fee-for-service cases | 5,774 | 505,568 |
| Growth since 2019 (Medicare FFS) | −6.9%/yr | +2.5%/yr |
| Forecast cases (Medicare FFS) | 6,110 in 2030 | 587,700 in 2030 |
| Forecast growth | +1%/yr to 2030 | +2.5%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 88.9 | 215.0 |
| Medicare Advantage share | 39% | 60% |
| Out of hospital | 51% (−2 pts since 2019) | 54% (+1 pts since 2019) |
| Cases per surgeon | 170 | 378 |
| Top 10 surgeons' share | 69% | 13% |
| Surgeons growing | 7 | 263 |
| New since the base year | 9 | 460 |
| Likely to stop billing it | 5 by 2026 | 210 by 2026 |
| Forecast miss, 1 year (procedure) | 3% | 3% |
| Company payments per surgeon | $4,654 | $1,233 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.